XML 77 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Revenues:        
Revenues $ 29,201 $ 23,002 $ 81,075 $ 66,351
Cost of revenues 9,268 6,796 25,688 19,686
Gross profit 19,933 16,206 55,387 46,665
Operating expenses:        
Research and development 3,962 3,157 10,791 6,952
Sales, general and administrative 26,792 18,833 72,360 53,628
Litigation 604 1,329 4,427 4,143
Amortization of intangible assets 172 187 526 551
Transaction-related expenses   66   1,546
Gain on settlement       (6,168)
Restructuring   167 60 758
Total operating expenses 31,530 23,739 88,164 61,410
Operating loss (11,597) (7,533) (32,777) (14,745)
Total other expenses, net (2,926) (1,754) (6,966) (5,183)
Loss from continuing operations before taxes (14,523) (9,287) (39,743) (19,928)
Income tax provision (benefit) 20 26 122 (1,697)
Loss from continuing operations (14,543) (9,313) (39,865) (18,231)
Loss from discontinued operations, net of applicable taxes (24) (42) (106) (116)
Net loss $ (14,567) $ (9,355) $ (39,971) $ (18,347)
Net loss per share, basic and diluted:        
Continuing operations $ (0.26) $ (0.22) $ (0.81) $ (0.56)
Discontinued operations 0.00 0.00 0.00 0.00
Net loss per share, basic and diluted $ (0.26) $ (0.22) $ (0.81) $ (0.56)
Shares used in calculating basic and diluted net loss per share 55,736 42,497 49,252 32,658
United States Product        
Revenues:        
Revenues $ 28,051 $ 20,996 $ 77,099 $ 60,606
International Supply Agreement        
Revenues:        
Revenues $ 1,150 $ 2,006 $ 3,976 $ 5,745